Small-Cap
KULR Secures $30 Million Battery Supply Deal, Accelerating U.S. Energy Storage Expansion
Five-year agreement with Caban Energy strengthens domestic manufacturing and positions KULR at the center of mission-critical power infrastructure. KULR Technology...
XTL Biopharmaceuticals Makes Bold Bet on Autism Breakthrough with NeuroNOS Acquisition
Transformative deal targets the biological roots of autism, opening a new frontier in disease-modifying therapy. XTL Biopharmaceuticals has taken a...
AZIO AI Secures $107 Million Government GPU Deal, Signaling a New Era for AI Infrastructure in Southeast Asia
Landmark Nvidia B300 order and expanding public-sector pipeline position AZIO AI as a rising force in sovereign AI computing AZIO...
Ironwood Pharmaceuticals Lays Out Ambitious 2026 Outlook
Strong LINZESS growth, rising profitability, and pipeline progress underpin confidence despite pricing changes Ironwood Pharmaceuticals (IRWD) entered 2026 with a...
Brand Engagement Network Secures New Pharma AI Project, Expanding Healthcare Footprint
Deal with global ad agency highlights rising demand for secure generative AI in regulated industries Brand Engagement Network (BNAI) announced...
FDA Approves YARTEMLEA as First-Ever Treatment for TA-TMA
Omeros secures landmark approval for a life-saving therapy in adults and children following stem cell transplant The U.S. Food and...
Highway Holdings Moves to Expand Automotive Capabilities With German Acquisition
Proposed majority stake in Regent-Feinbau aims to strengthen OEM exposure and unlock growth in China and Europe Highway Holdings Limited...
A Breakthrough in Knee Osteoarthritis: Enlivex Reports Promising Six-Month Results for Allocetra
Sustained pain reduction, improved mobility, and strong safety profile position Allocetra™ as a potential game-changer for aging patients Enlivex Therapeutics...
KULR Technology Posts Record Q3 Revenue as It Expands Deep Into Frontier Tech and Bitcoin Infrastructure
Despite widening losses, the company accelerates investments in aerospace batteries, AI robotics, and Bitcoin mining partnerships KULR Technology Group (KULR),...
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6
Study in eBioMedicine shows strong disease control and survival benefits across multiple tumor types with minimal toxicity Intensity Therapeutics (INTS),...
